Grace Koennecke

2025: a big year for emergency psychiatry. Don't miss any of our Special Report articles!

New findings from the RESTORE-LIFE study suggest the potential benefits of VNS treatment in patients with DTD.

The first patient has been dosed in MindMed’s phase 3 Emerge study evaluating the efficacy of MM120 ODT.

Adherence, switching, and quality of life are top concerns in BDI, and schizophrenia.